{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:38:35Z","timestamp":1770223115550,"version":"3.49.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cAI in medicine\u201d from the Land Tirol"},{"DOI":"10.13039\/501100020617","name":"Austrian Society of Gastroenterology and Hepatology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020617","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020617","name":"Austrian Society of Gastroenterology and Hepatology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020617","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background: Interleukin-38 (IL-38) is an anti-inflammatory IL-1\u2014family cytokine implicated in limiting tissue injury by its anti-inflammatory character. We evaluated the diagnostic discrimination and prognostic relevance in steatotic liver disease (SLD). Methods: We conducted a prospective, monocentric cohort analysis of 184 patients with SLD (n = 176) and healthy controls (n = 8). We tested group differences using Mann\u2013Whitney U or Kruskal\u2013Wallis; determined diagnostic quality using ROC curves. Logistic regression was used to assess the relationship with decompensation. Associations with MELD and routine laboratory parameters were modeled using Spearman correlation and linear regression. We analyzed survival using Kaplan\u2013Meier and Cox regression. Findings: IL-38 concentrations were found to be higher in decompensated (n = 94) than in compensated patients (n = 82) (p &lt; 0.001). MELD was positively associated with IL-38 (p &lt; 0.001; 95% CI 0.057\u20130.120). This corresponds to a 9.2% increase in IL-38 per 1-point increase in MELD (95% CI 5.9\u201312.7%). IL-38 correlated positively with the MELD score (p &lt; 0.001) and with bilirubin\/AST\/LDH. In the combination model (MELD + IL-38 \u00b1 CRP), a very good AUC \u2248 0.92 was achieved. Conclusion: IL-38 reflects the severity of steatotic liver disease and is therefore a potentially predictive biomarker for early risk stratification and therapy monitoring.<\/jats:p>","DOI":"10.3390\/cells15030280","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:49:44Z","timestamp":1770036584000},"page":"280","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interleukin-38: A Candidate Biomarker for Disease Severity in Advanced Steatotic Liver Disease"],"prefix":"10.3390","volume":"15","author":[{"given":"Valeria","family":"Wagner","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5901-624X","authenticated-orcid":false,"given":"Michael","family":"Mederer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Enrich","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5416-7841","authenticated-orcid":false,"given":"Veronika","family":"Cibulkova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Piater","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-068X","authenticated-orcid":false,"given":"Andreas","family":"Zollner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Giquel-Fernandes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-9953","authenticated-orcid":false,"given":"Maria","family":"Effenberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m4747","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5009\/gnl20127","article-title":"Recent Epidemiology of Nonalcoholic Fatty Liver Disease","volume":"15","author":"Murag","year":"2021","journal-title":"Gut Liver"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Petrescu, M., Vlaicu, S.I., Cium\u0103rnean, L., Milaciu, M.V., M\u0103rginean, C., Florea, M., Vesa, \u0218.C., and Popa, M. (2022). Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. Medicina, 58.","DOI":"10.3390\/medicina58050641"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e176345","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathopysiology, clinical management and effects of weight losss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"155808","DOI":"10.1016\/j.cyto.2022.155808","article-title":"Multifaceted roles of IL-38 in inflammation and cancer","volume":"151","author":"Huard","year":"2022","journal-title":"Cytokine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1074\/jbc.M010095200","article-title":"Cloning and characterization of IL-1HY2, a novel interleukin-1 family member","volume":"276","author":"Lin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.1002\/iid3.991","article-title":"The emerging role of IL-38 in diseases: A comprehensive review","volume":"11","author":"Chen","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Xie, L., Huang, Z., Li, H., Liu, X., Zheng, S., and Su, W. (2019). IL-38: A New Player in Inflammatory Autoimmune Disorders. Biomolecules, 9.","DOI":"10.3390\/biom9080345"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jmcb\/mjw006","article-title":"Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses","volume":"8","author":"Mora","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Teufel, L.U., Netea, M.G., van de Veerdonk, F.L., Dinarello, C.A., Joosten, L.A.B., and Arts, R.J.W. (2023). Opposing Effects of Interleukin-36\u03b3 and Interleukin-38 on Trained Immunity. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032311"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Han, M.-M., Yuan, X.-R., Shi, X., Zhu, X.-Y., Su, Y., Xiong, D.-K., Zhang, X.-M., Zhou, H., and Wang, J.-N. (2021). The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.732790"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12944-022-01676-0","article-title":"Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease","volume":"21","author":"Cao","year":"2022","journal-title":"Lipids Health Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e31184","DOI":"10.1002\/jcp.31184","article-title":"Interleukin-38 alleviates hepatic steatosis through AMPK\/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models","volume":"239","author":"Sun","year":"2024","journal-title":"J. Cell Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3748\/wjg.v22.i18.4529","article-title":"Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B","volume":"22","author":"Wang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.intimp.2016.09.023","article-title":"IL-38 alleviates concanavalin A-induced liver injury in mice","volume":"40","author":"Yuan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing consensus in pral hyertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: Management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients with Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Lazarus","year":"2023","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"630265","DOI":"10.1155\/2015\/630265","article-title":"Interleukin-1 Family Cytokines in Liver Diseases","volume":"2015","author":"Tsutsui","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.imbio.2016.10.012","article-title":"In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)\/lpr mice","volume":"222","author":"Chu","year":"2017","journal-title":"Immunobiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21501319241309170","DOI":"10.1177\/21501319241309168","article-title":"Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians","volume":"15","author":"Peterseim","year":"2024","journal-title":"J. Prim. Care Community Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2018.11.114","article-title":"Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance","volume":"508","author":"Xu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"108315","DOI":"10.1016\/j.clim.2019.108315","article-title":"IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo","volume":"210","author":"Chai","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000510915","article-title":"Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients","volume":"30","author":"Zarrabi","year":"2021","journal-title":"Med. Princ. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Teufel, L.U., de Graaf, D.M., Netea, M.G., Dinarello, C.A., Joosten, L.A.B., and Arts, R.J.W. (2022). Circulating interleukin-38 concentrations in healthy adults. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.964365"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155824","DOI":"10.1016\/j.cyto.2022.155824","article-title":"Interleukin-38 in Health and Disease","volume":"152","author":"Teufel","year":"2022","journal-title":"Cytokine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure","volume":"64","author":"Stauber","year":"2016","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chrnoic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ma, J., Wu, N., Yuan, Z., Chen, Y., Li, C., Xie, W., Zhang, Z., Li, Y., and Zhong, L. (2022). Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.1072164"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2147\/IJGM.S417471","article-title":"Serum IL-38 Level Was Associated with Incidence of MACE in the STEMI Patients","volume":"16","author":"Lu","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalitiy","volume":"74","author":"Costa","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"Aagaard","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/j.gastro.2020.01.029","article-title":"Peritoneal Level of CD206 Associates with Mortality and an Inflammatory Macrophage Phenotype in Patients with Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis","volume":"158","author":"Stengel","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2024.09.042","article-title":"Alcohol-Associated Liver Disease: Managing the Dual Pathology of Liver Disease and of Alcohol Use Disorder","volume":"168","author":"Arab","year":"2025","journal-title":"Gastroenterology"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/3\/280\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:18:15Z","timestamp":1770182295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/3\/280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cells15030280"],"URL":"https:\/\/doi.org\/10.3390\/cells15030280","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}